Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
Articles
Page 20 of 22
-
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P48
-
Activation of interferon signaling pathway in primary effusion lymphoma cells by inhibition of viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P47 -
Geographic variation of the prevalence of Kaposi's sarcoma-associated herpesvirus and risk factors for transmission in women from 8 countries in four continents
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P46 -
Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P45 -
The spectrum of HIV-associated cancers in a South African black population: results from a case-control study, 1995–2004
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P44 -
CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P43 -
Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P42 -
Cervical and anal HPV infection and dysplasia in HIV-infected women
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P40 -
Exploring Kaposi's sarcoma-associated herpesvirus latent genes' role in viral lymphomagenesis using transgenic mice
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P39 -
Initial experience of an anal dysplasia clinic for HIV-infected men in Seattle, WA
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P38 -
Cellular gene regulation by K13/VFLIP of Kaposi's sarcoma-associated herpesvirus
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P35 -
Pathology of rituximab-induced Kaposi sarcoma flare: role of B-cell depletion
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P33 -
Protein tyrosine phosphatase nonreceptor 13 (PTPN13) is targeted by human papillomavirus 16 E6 in cervical epithelium
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P31 -
Extracellular matrix promotes pathogenic treatment of AIDS-associated Kaposi's sarcoma at Hôpital General in Yaoundé, Cameroon
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P30 -
AKT/TSC/mTOR activation by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: novel therapeutic targets for the treatment of Kaposi's sarcoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P29 -
Genetic resistance to GAHV-2 induced lymphoma in the chicken model
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P28 -
MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P26 -
Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P25 -
Profiling viral and host microRNA expression in cells infected with KSHV and EBV
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O23 -
Bortezomib-induced enzyme-targeted radiotherapy (BETR) for AIDS-related malignancies: efficacy assessment by Monte Carlo and dosimetry modeling
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P23 -
Burkitt lymphoma in Brazil is characterized by geographically distinct clinico-pathological features and lack of p53 mutations
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P22 -
Implementation of a "see and treat" cervical cancer prevention program linked to HIV care in Zambia
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O21 -
Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P21 -
KSHV seroprevalence, and blood and saliva viral loads in the HIV-infected population of south Texas
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P20 -
Profiling of cellular and viral microRNAs in Kaposi sarcoma and viral-associated lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O19 -
The role of the TRAF2/3 binding site in LMP1 and CD40 signaling
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P19 -
Kaposi's sarcoma-associated herpes virus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P18 -
Kaposi sarcoma incidence in the Swiss HIV cohort study before and after highly active antiretroviral therapy
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P17 -
Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O16 -
Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P16 -
Marijuana use and cervical HPV/neoplasia
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P15 -
Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O14 -
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS malignancies consortium clinical trials 010 and 034
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P14 -
An invasion mechanism for human papillomavirus related cancers: HPV 16 E6 degrades PTPN13 allowing enhanced map kinase signaling
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O13 -
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O12 -
Regulatory T cells are present in Kaposi's sarcoma and increasingly frequent in advanced disease
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P12 -
HIV induces the expression of activation-induced cytidine deaminase (AICDA) in B cells through a direct interaction between virion-associated CD40L and CD40
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O11 -
A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P11 -
Survival and prognosis of HIV-associated non-Hodgkin-lymophma in the era of combined anti-retroviral therapy, a European multi-cohort study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P10 -
Dendritic cell-mediated infection of primary B cells with KSHV
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P9 -
Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O9 -
Therapeutic options in AIDS related Kaposi's sarcoma: a 5-year Nigerian review
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P8 -
High resolution profiling of DNA copy number and gene expression changes in AIDS-related lymphoma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O8 -
Evaluation of Epstein-Barr virus (EBV) and human herpes virus-8 (HHV-8) in HIV-associated persistent generalized lymphadenopathy (PGL)
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P7 -
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O7 -
Suppression of galectin-3 in KSHV infected DMVEC cells and Kaposi's sarcoma: implications for tumorigenesis
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P5 -
Four year survival in untreated AIDS related-Kaposi sarcoma (AIDS-KS) in Jos, Nigeria
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P3 -
Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O2 -
AIDS-associated plasmablastic lymphoma presenting as a poorly differentiated esophageal tumor: a diagnostic dilemma
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P2 -
A retrospective analysis of HIV-associated Kaposi's sarcoma in patients with non-detectable HIV viral loads and CD4+ counts greater than 300 cells/μL
Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P1
-
Affiliated with
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
3.8 - 5-year Impact Factor
1.040 - SNIP (Source Normalized Impact per Paper)
0.583 - SJR (SCImago Journal Rank)2023 Speed
14 days submission to first editorial decision for all manuscripts (Median)
112 days submission to accept (Median)2023 Usage
687,750 downloads
813 Altmetric mentions
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.